Patents Assigned to Supermus Pharmaceuticals, Inc.
  • Once daily dosage forms of trospium
    Patent number: 7763635
    Abstract: A pharmaceutical composition of a pharmaceutically acceptable trospium salt, with upon administration to a human patient generates an average steady state blood levels of trospium with a minimum (Cmin) and maximum (Cmax) blood levels of about 0.5-2.5 ng/ml and about 2.0-6.0 ng/ml, respectively.
    Type: Grant
    Filed: August 17, 2007
    Date of Patent: July 27, 2010
    Assignee: Supermus Pharmaceuticals, Inc.
    Inventors: Argaw Kidane, Henry H. Flanner, Padmanabh Bhatt, Arash Raoufinia